Novel Cationic 17-Estradiol-Substituted-Estradiol Derivatives with Anti-cancer Activity
Implementing Organization
Indian Institute of Chemical Technology (IICT)
Project Overview
Tested preclinically in triple negative breast tumor animal model (the most aggressive breast cancer model). The molecule is co-formulated in liposomes and developed further in association with Mayo Clinic, USA for treating multiple other aggressive cancers such as melanoma, pancreatic cancer.
Indian Institute of Chemical Technology (IICT)
Acces sibility Controls